Beam Therapeutics Inc. (BEAM) Operating cash flow 2019–2025
Beam Therapeutics Inc. (BEAM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$345.1MFY2025 · since FY2019: -$72.0M → -$345.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$345.1M | +0.6% |
| FY2024 | -$347.2M | -132.7% |
| FY2023 | -$149.2M | -762.3% |
| FY2022 | $22.5M | +134.0% |
| FY2021 | -$66.3M | +30.8% |
| FY2020 | -$95.7M | -33.0% |
| FY2019 | -$72.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BEAM financial trends
BEAM RevenueBEAM Net incomeBEAM Net marginBEAM Gross profitBEAM Gross marginBEAM Operating incomeBEAM Operating marginBEAM Free cash flowBEAM Capital expendituresBEAM Return on equityBEAM Stock buybacksBEAM Dividends paidBEAM Total assetsBEAM Total liabilitiesBEAM Shareholders’ equityBEAM overview →